コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 sults in the clinically distinct disorder of Prader-Willi syndrome.
2 letion or uniparental disomy, results in the Prader-Willi syndrome.
3 oventilation syndrome, myelomeningocele, and Prader-Willi syndrome.
4 d and reliable in the molecular diagnosis of Prader-Willi syndrome.
5 es POMC circuit deficits in a mouse model of Prader-Willi Syndrome.
6 is linked to the neurodevelopmental disease Prader-Willi syndrome.
7 o how they contribute to the pathogenesis of Prader-Willi syndrome.
8 of several that are deleted in patients with Prader-Willi syndrome.
9 range imprinted gene expression resulting in Prader-Willi syndrome.
10 l as patients presenting with trisomy 21 and Prader-Willi syndrome.
11 y in children with chronic renal failure and Prader-Willi syndrome.
12 me of the clinical features of the polygenic Prader-Willi syndrome.
13 somy, accounts for >95% of all patients with Prader-Willi syndrome.
14 comparable to that of Williams, Angelman and Prader-Willi syndromes.
15 large deletions associated with Angelman and Prader-Willi syndromes.
16 the region commonly deleted in Angelman and Prader-Willi syndromes.
18 HLH2 gene is associated with obesity; and in Prader-Willi syndrome, a condition characterized by obes
19 small population that is selectively lost in Prader-Willi syndrome, a condition involving insatiable
20 , and loss of MAGEL2 is also associated with Prader-Willi syndrome, a neurodevelopmental genetic diso
21 everal neurobehavioural disorders, including Prader-Willi syndrome, affective disorders and obsessive
26 ole of recombinant growth hormone therapy in Prader-Willi syndrome and the genetic information respon
27 tein that suppresses obesity associated with Prader-Willi syndrome - and reduced HFD-induced non-alco
28 sychological disorders, such as Angelman and Prader-Willi syndromes, and autism spectrum disorder.
30 ndromes involving brain dysfunction, such as Prader-Willi syndrome, Angelman syndrome, Turner's syndr
31 chromosome 15 (inv dup[15]) that include the Prader-Willi syndrome/Angelman syndrome (PWS/AS) chromos
33 nd asymmetry of L1 elements at the imprinted Prader-Willi syndrome/Angelman syndrome (PWS/AS) locus o
38 '/B levels in response to the loss of SmN in Prader-Willi syndrome brain tissue, potentially reducing
40 nd might also be therapeutically relevant to Prader-Willi syndrome, characterized after infancy by hy
41 lly expressed, imprinted gene located in the Prader-Willi syndrome critical region (chromosome 15q11-
46 cy and conditions such as Turner's syndrome, Prader-Willi syndrome, intrauterine growth restriction,
51 e nuclei to distinguish between Angelman and Prader-Willi syndrome patient samples with uniparental d
52 ately regulated imprinted domain affected in Prader-Willi syndrome patients with imprinting mutations
54 e by an upstream break may contribute to the Prader-Willi syndrome phenotype and that expression of S
64 Imprinted gene expression associated with Prader-Willi syndrome (PWS) and Angelman syndrome (AS) i
66 in the human genome are associated with the Prader-Willi Syndrome (PWS) and Beckwith-Wiedemann Syndr
68 Human chromosome 15q11-q13 encompasses the Prader-Willi syndrome (PWS) and the Angelman syndrome (A
70 ted genes such as Angelman syndrome (AS) and Prader-Willi syndrome (PWS) can have a mutation in the i
71 es in prefrontal cortex (PFC) of donors with Prader-Willi syndrome (PWS) compared to controls and exa
76 rowth hormone (hGH) therapy in children with Prader-Willi syndrome (PWS) improves linear growth, body
103 at a cluster of four imprinted genes in the Prader-Willi syndrome (PWS) locus on chromosome 7 and ge
104 egion or by uniparental disomy 15 results in Prader-Willi syndrome (PWS) or Angelman syndrome (AS), r
105 ave been identified in several families with Prader-Willi syndrome (PWS) or Angelman syndrome who sho
109 the smallest deletion region involved in the Prader-Willi syndrome (PWS) within chromosome 15q11-q13.
112 ewborn screening for Angelman syndrome (AS), Prader-Willi syndrome (PWS), and chromosome 15 duplicati
113 human neurodevelopmental disorders including Prader-Willi syndrome (PWS), Angelman syndrome (AS) and
114 ps to the chromosomal region associated with Prader-Willi Syndrome (PWS), are highly enriched in the
115 ifferent age and sex alongside patients with Prader-Willi syndrome (PWS), Beckwith-Wiedemann syndrome
116 genes are deleted in most patients with the Prader-Willi syndrome (PWS), diminished HTR2C receptor a
118 ponsible for both Angelman syndrome (AS) and Prader-Willi syndrome (PWS), two clinically distinct neu
119 ead to neurodevelopmental disorders, such as Prader-Willi syndrome (PWS), which results from the dele
120 gene expression from this region results in Prader-Willi syndrome (PWS), while absence of maternal g
121 estigated in Autism Spectrum Disorder (ASD), Prader-Willi Syndrome (PWS), Williams Syndrome (WS) and
133 Although MAGEL2 is deleted in most cases of Prader-Willi syndrome (PWS, OMIM #176270), SYS presents
134 script), H19, and IPW (imprinted gene in the Prader-Willi syndrome region), which are transcribed but
135 aternal contribution from the locus, whereas Prader-Willi syndrome results from the absence of patern
136 eletions found in most cases of Angelman and Prader Willi syndrome, the duplications appear to be med
138 Patients with Angelman syndrome (AS) and Prader-Willi syndrome with mutations in the imprinting p